Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in <i>ApoE</i>^−/− Mice

Bacille-Calmette Guérin (BCG) modulates atherosclerosis development in experimental animals, but it remains unclear whether neonatal BCG vaccination is pro- or anti-atherogenic. Many animal models differ fundamentally from BCG administration to human infants in terms of age, vaccine preparation, dos...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Siroon Bekkering, Krishan Singh, Hui Lu, Albert P. Limawan, Claudia A. Nold-Petry, Megan J. Wallace, Nigel Curtis, Salvatore Pepe, Michael Cheung, David P. Burgner, Timothy Moss
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2022-10-01
Rangatū:	Biology
Ngā marau:	atherosclerosis neonatal vaccination BCG inflammation <i>ApoE</i><sup>−/−</sup>
Urunga tuihono:	https://www.mdpi.com/2079-7737/11/10/1511
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!